Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	84.02	124.29	143.74	151.79	280.12
Short-Term Investments	470.5	657.04	606.35	847.12	677.95
Cash & Short-Term Investments	554.52	781.32	750.09	998.92	958.07
Cash Growth	-29.03%	4.16%	-24.91%	4.26%	41.30%
Accounts Receivable	-	-	-	0.31	0.4
Other Current Assets	23.76	27.88	20.02	20.28	17.77
Total Current Assets	578.28	809.2	770.1	1,020	976.24
Net Property, Plant & Equipment	41.72	57.67	68.87	75.39	27.32
Other Intangible Assets	-	2.3	2.3	2.3	2.3
Other Long-Term Assets	1.34	2.12	2.71	2.58	2.58
Total Assets	621.33	871.3	843.98	1,100	1,008
Accounts Payable	7.71	14.1	9.21	10.58	8.28
Accrued Expenses	13.65	21.24	14.89	22.7	13.56
Current Portion of Leases	3.77	5.73	4.96	4.28	1.84
Unearned Revenue	-	7.68	-	-	0.25
Other Current Liabilities	0.46	1.99	1.2	26.15	0.4
Total Current Liabilities	25.58	50.73	30.27	63.71	24.32
Long-Term Leases	28.69	42.78	48.5	53.47	21.06
Other Long-Term Liabilities	-	-	13.21	32.38	65.26
Total Long-Term Liabilities	28.69	42.78	61.71	85.84	86.31
Total Liabilities	54.27	93.5	91.98	149.55	110.64
Common Stock	0.17	0.17	0.13	0	0.11
Additional Paid-in Capital	2,581	2,517	2,153	2,019	1,667
Accumulated Other Comprehensive Income	0.73	-0.99	-0.2	-10.42	-1.09
Retained Earnings	-2,015	-1,738	-1,401	-1,059	-768.1
Shareholders' Equity	567.06	777.79	752	950.22	897.81
Total Liabilities & Equity	621.33	871.3	843.98	1,100	1,008
Total Debt	32.46	48.5	53.47	57.74	22.9
Net Cash (Debt)	522.06	732.82	696.62	941.18	935.17
Net Cash Growth	-28.76%	5.20%	-25.98%	0.64%	43.07%
Net Cash Per Share	3.04	5.13	5.68	8.39	9.83
Book Value	567.06	777.79	752	950.22	897.81
Book Value Per Share	3.30	5.44	6.13	8.47	9.44
Tangible Book Value	567.06	775.49	749.7	947.92	895.51
Tangible Book Value Per Share	3.30	5.43	6.12	8.45	9.41

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q